Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SYNERGY China: A Prospective, Multicenter Trial to Assess the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)

NCT02499692 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02499692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02499692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SYNERGY China: A Prospective, Multicenter Trial to Assess the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
August 31, 2017
Enrollment
103 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases